SELLAS Life Sciences Group, Inc. (SLS)

3.73 +0.20 (+5.67%) USD  |  NASDAQ  |  Feb 06, 16:00
3.75 +0.02 (+0.54%) After-Hours: 20:00
More

SELLAS Life Sciences Group Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for SLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
GT Biopharma, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade
Geron Corp. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
ADMA Biologics, Inc. Upgrade